Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Earth Science Tech ( (ETST) ).
On August 19, 2025, Earth Science Tech, Inc. announced that its Board of Directors approved a reduction in the company’s authorized shares of common stock from 350 million to 300 million. This decision reflects the board’s confidence in the company’s financial health and strategic plan, aiming to prevent unnecessary shareholder dilution and protect long-term shareholder value.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
Earth Science Tech’s overall stock score is driven by strong corporate events and positive technical analysis, indicating a promising growth trajectory. Financial performance shows recovery, though past instability remains a concern. Valuation is moderate, reflecting balanced growth potential.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company’s operations include compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries, such as RxCompoundStore.com, LLC, Peaks Curative, LLC, and others.
Average Trading Volume: 92,818
Technical Sentiment Signal: Buy
Current Market Cap: $60.33M
Learn more about ETST stock on TipRanks’ Stock Analysis page.